Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
暂无分享,去创建一个
F. Lordick | W. Hohenberger | C. Rödel | R. Sauer | R. Hermann | M. Flentje | D. Arnold | T. Liersch | T. Reese | J. Haier | N. Schwella | A. Fürst | M. Hipp | G. Hellmich | M. Bieker | Hermann Ewald | H. Sülberg | M. Bieker
[1] M. Bains,et al. Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] N. Rothman,et al. Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] F. Calvo,et al. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] S. Ricci,et al. Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: Results of an international multicenter phase II study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] G. Kundt,et al. Postoperative Chemotherapy May Not Be Necessary for Patients With ypN0-Category After Neoadjuvant Chemoradiotherapy of Rectal Cancer , 2006, Diseases of the colon and rectum.
[6] C. Sempoux,et al. What is the best way to predict disease-free survival after preoperative radiochemotherapy for rectal cancer patients: tumor regression grading, nodal status, or circumferential resection margin invasion? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] R. Glynne-Jones,et al. The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been? , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] A. Makris,et al. Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? , 2006, British Journal of Cancer.
[9] A. Norman,et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] R. Glynne-Jones,et al. A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] C. Sempoux,et al. Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] Rainer Fietkau,et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] L. Collette,et al. Preoperative radiation (Preop RT) in rectal cancer: Effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial , 2005 .
[14] N. Wolmark,et al. A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Survival results of NSABP Protocol C-07 , 2005 .
[15] S. Miles,et al. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Rainer Fietkau,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.
[17] T. Conroy,et al. Preoperative (preop) radiotherapy (RT) + 5FU/folinic acid (FA) in T3,4 rectal cancers: Preliminary results of the FFCD 9203 randomized trial , 2004 .
[18] T. Hickish,et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.
[19] W. Hohenberger,et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] C. N. Coleman,et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.
[21] N. Magné,et al. Oxaliplatin–5-Fluorouracil and Ionizing Radiation , 2003, Oncology.
[22] A. Norman,et al. Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer , 2003, British Journal of Cancer.
[23] J. Tepper,et al. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] P. Marchetti,et al. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. , 2002, International journal of radiation oncology, biology, physics.
[25] B. Reigner,et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients , 2000, Cancer Chemotherapy and Pharmacology.
[26] H. Ishitsuka,et al. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] O. Dworak,et al. Pathological features of rectal cancer after preoperative radiochemotherapy , 1997, International Journal of Colorectal Disease.
[28] H. Wieand,et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. , 1994, The New England journal of medicine.
[29] W. Meyers,et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. , 1991, The New England journal of medicine.
[30] T R Fleming,et al. One-sample multiple testing procedure for phase II clinical trials. , 1982, Biometrics.